Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants.

MLA

Offensperger, Fabian, et al. “Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants.” Cell Chemical Biology, vol. 27, no. 12, Dec. 2020, p. 1510. EBSCOhost, https://doi.org/10.1016/j.chembiol.2020.08.017.

APA

Offensperger, F., Müller, F., Jansen, J., Hammler, D., Götz, K. H., Marx, A., Sirois, C. L., Chamberlain, S. J., Stengel, F., & Scheffner, M. (2020). Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants. Cell Chemical Biology, 27(12), 1510. https://doi.org/10.1016/j.chembiol.2020.08.017

Chicago

Offensperger, Fabian, Franziska Müller, Jasmin Jansen, Daniel Hammler, Kathrin H Götz, Andreas Marx, Carissa L Sirois, Stormy J Chamberlain, Florian Stengel, and Martin Scheffner. 2020. “Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants.” Cell Chemical Biology 27 (12): 1510. doi:10.1016/j.chembiol.2020.08.017.